Federated Hermes
ROIV icon

Federated Hermes’s Roivant Sciences ROIV Stock Holding History

Federated Hermes’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.08M Sell
30,467
-820
-3% -$24.2K ﹤0.01% 1137
2026
Q1 		$867K Buy
31,287
+1,982
+7% +$50.9K ﹤0.01% 1158
2025
Q4 		$636K Buy
29,305
+236
+0.8% +$4.66K ﹤0.01% 1243
2025
Q3 		$440K Buy
29,069
+1,320
+5% +$16.3K ﹤0.01% 1366
2025
Q2 		$313K Sell
27,749
-160
-0.6% -$1.73K ﹤0.01% 1431
2025
Q1 		$282K Sell
27,909
-1,662
-6% -$18K ﹤0.01% 1443
2024
Q4 		$350K Sell
29,571
-45,152
-60% -$534K ﹤0.01% 1396
2024
Q3 		$862K Buy
74,723
+36,513
+96% +$416K ﹤0.01% 1174
2024
Q2 		$404K Buy
38,210
+894
+2% +$9.8K ﹤0.01% 1362
2024
Q1 		$393K Buy
+37,316
New +$402K ﹤0.01% 1371

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Federated Hermes's ROIV Position: Q2 2026 in Review

Federated Hermes reduced its Roivant Sciences (ROIV) stake by 2.6% in Q2 2026, selling an estimated $24.2K and leaving 30,467 shares worth $1.08M. The position accounts for ﹤0.01% of the portfolio, ranked #1137.

Federated Hermes first reported a position in ROIV in Q1 2024 and has held it in 10 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Federated Hermes held 30,467 shares of Roivant Sciences worth $1.08M as of Q2 2026.
  • Federated Hermes sold 820 Roivant Sciences shares in Q2 2026, an estimated $24.2K.
  • Roivant Sciences made up ﹤0.01% of Federated Hermes's portfolio in Q2 2026, its #1137 holding.
  • Federated Hermes first reported a position in Roivant Sciences in Q1 2024 and has held it in 10 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.